Proactive Investors - Run By Investors For Investors

Genedrive to premiere Hepatitis C test at Asia-Pacific medical exhibition

The AIM-listed diagnostics company said the kit would make its debut at the MEDLAB Asia Pacific Exhibition & Congress in Singapore
Medical Microscope
The conference is a significant event in the region for leading companies to showcase their technologies and innovations

Genedrive PLC (LON:GDR) has said it will premiere its HCV ID Kit in the Asia-Pacific (APAC) region on 2-4 April 2018.

The AIM-listed diagnostics company said the kit would make its debut at the MEDLAB Asia Pacific Exhibition & Congress in Singapore.

READ: Genedrive extends global coverage with new distribution agreement in India

The conference, the firm said, is a significant and highly attended event in the Asia Pacific region for leading companies to showcase their technologies and innovations in the field of laboratory diagnostics. With over 4,000 delegates from around the world, the congress features products in many areas including point of need and infectious diseases.

The company’s APAC debut comes after it announced its first commercial sales of instruments and assays to Sysmex Europe GmbH to cover Europe, Middle East and Africa and Sysmex Asia Pacific Pte Ltd for the Asia Pacific region, excluding India.

View full GDR profile View Profile

Genedrive PLC Timeline

Big Picture
May 23 2019

Related Articles

rasuvo
May 30 2019
The Toronto-based company’s leading products are Rasuvo and Metoject, a unique formulation of methotrexate that is designed to treat rheumatoid arthritis and other auto-immune diseases
young girl with allergy
April 29 2019
The sell-off that followed the recent disappointment of Allergy’s PQ Birch jab means now might be a good time to invest, according to City broker finnCap
word cancer under magnifying glass
May 01 2019
The oncology-focused biotech is a mid-clinical-stage therapeutics company.

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use